GENEVA, Oct. 4 -- ZHONGMOU THERAPEUTICS CO., LTD. (4F, Building C4 Middle West, Biolake, No 666 High-tech Avenue, Donghu New Technology Development ZoneWuhan, Hubei 430074), 中眸医疗科技(武汉)有限公司 (中国湖北省武汉市东湖高新区高新大道666号光谷生物城生物创新园C4中西栋4层) filed a patent application (PCT/CN2025/090797) for "USE OF MULTIPLE PROMOTERS EFFICIENTLY TARGETING ON-TYPE BIPOLAR CELLS IN GENE THERAPY TECHNOLOGY" on Apr 24, 2025. With publication no. WO/2025/201567, the deta...